Bone Biologics Corporation

BBLG
1,723
-0,1243 (-6,73%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202422:15BWBone Biologics Announces Closing of $2.0 Million Public..
05/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
04/3/202423:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
04/3/202415:15BWBone Biologics Announces Pricing of $2.0 Million Public..
01/3/202414:05EDGAR2Form 8-K - Current report
01/3/202414:00BWBone Biologics Reports Progress With NB1 Clinical Program
26/2/202422:50EDGAR2Form S-1/A - General form for registration of securities..
23/2/202423:09EDGAR2Form S-1/A - General form for registration of securities..
21/2/202423:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202400:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202416:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202423:09EDGAR2Form S-1 - General form for registration of securities under..
19/1/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:21EDGAR2Form S-3/A - Registration statement under Securities Act of..
12/1/202423:15EDGAR2Form 8-K - Current report
11/1/202414:15EDGAR2Form 8-K - Current report
11/1/202414:00BWBone Biologics Appoints Healthcare Finance Veteran Robert E...
10/1/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202414:15EDGAR2Form 8-K - Current report
10/1/202414:00BWBone Biologics Regains Compliance with Nasdaq Continued..
05/1/202423:15EDGAR2Form S-3 - Registration statement under Securities Act of..
02/1/202423:15EDGAR2Form 8-K - Current report
02/1/202421:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/12/202323:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/12/202314:05EDGAR2Form 8-K - Current report
18/12/202314:00BWBone Biologics Announces 1-for-8 Reverse Stock Split
13/12/202315:15EDGAR2Form 8-K - Current report
27/11/202312:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/11/202318:38BWBone Biologics Announces Closing of Registered Direct..
20/11/202313:46EDGAR2Form 8-K - Current report
20/11/202313:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/11/202313:00EDGAR2Form DEF 14A - Other definitive proxy statements
20/11/202312:50EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
16/11/202322:43BWBone Biologics Announces Registered Direct Offering Priced..
14/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:51EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202312:06EDGAR2Form 8-K - Current report
29/9/202323:19EDGAR2Form 8-K - Current report
26/9/202314:00BWBone Biologics Provides Scientific Update on NB1 Bone Graft..
20/9/202320:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202320:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202320:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202322:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/9/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:01EDGAR2Form 8-K - Current report
12/9/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,90 Min: 1,80 Max: 1,9418
Chiusura: 1,8473

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network